News & Updates
Filter by Specialty:
Reduced kidney function after stroke ups risk of recurrence, dementia
Patients with declining kidney function following a cerebrovascular event are at increased risk of major adverse cardiovascular events (MACE), dementia, and mortality at 2 years, according to a study. However, a higher risk of death is also noted for those with a large increase in kidney function.
Reduced kidney function after stroke ups risk of recurrence, dementia
17 Jul 2024
Bulky tumours in PCNSL tied to high local treatment failure
Systemic and intrathecal therapies are necessary for local control in patients with primary central nervous system lymphoma (PCNSL), but bulky tumours remain a problem, according to a study.
Bulky tumours in PCNSL tied to high local treatment failure
10 Jul 2024
Efgartigimod shows promise in treatment-resistant myasthenia gravis
Use of efgartigimod, a first-in-class investigational antibody fragment targeting the neonatal Fc receptor (FCRN), demonstrates both efficacy and safety in patients with refractory, treatment-resistant generalized myasthenia gravis (MG), as shown in a study presented at EAN 2024.
Efgartigimod shows promise in treatment-resistant myasthenia gravis
09 Jul 2024
Anti-CD20 show promise in multiple sclerosis after alemtuzumab
Treatment with anti-CD20 monoclonal antibodies appears to be a viable option for patients with relapsing-remitting multiple sclerosis (RRMS) who have uncontrolled disease following the use of alemtuzumab therapy, suggests a study presented at EAN 2024.
